Daniella Mehalik
Director of Finance/CFO at PSYCHEMEDICS CORPORATION
Daniella Mehalik active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PSYCHEMEDICS CORPORATION | Director of Finance/CFO | 26/11/2023 | - |
| Investor Relations Contact | - | - | |
| Treasurer | 26/11/2023 | - |
Career history of Daniella Mehalik
Former positions of Daniella Mehalik
| Companies | Position | Start | End |
|---|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 31/12/2020 | 31/12/2022 |
| DxTx Medical, Inc. | Comptroller/Controller/Auditor | 31/12/2018 | 31/12/2020 |
Training of Daniella Mehalik
| Carlow University Of | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PSYCHEMEDICS CORPORATION | Health Services |
| Private companies | 2 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
| DxTx Medical, Inc. |
- Stock Market
- Insiders
- Daniella Mehalik
- Experience
